25th Bethesda Conference

25th Conference of GP2A

The 25th Conference of GP2A was held on 31 August and 1 September 2017 in Liverpool, UK, with the aim of exchange of ideas and experience, particularly amongst young medicinal chemists. Topics included bioactive compounds from plants and lichens, and design and development of drugs. Abstracts of invited lectures, proffered oral presentations, flash presentations and posters presented during the...

BETHESDA CONFERENCE REPORT 33rd Bethesda Conference: Preventive Cardiology: How Can We Do Better?*

*The recommendations set forth in this report are those of the conference participants and do not necessarily reflect the official position of the American College of Cardiology Foundation. When citing this document, the American College of Cardiology Foundation would appreciate the following citation format: Preventive cardiology: how can we do better? 582 Fletcher et al.

BETHESDA CONFERENCE REPORT 28th Bethesda Conference: Practice Guidelines and the Quality of Care*

CSI: Bethesda

Summarn Recognition of psychological distress in patients with cancer. some of which can be ameliorated With appropriate intervention. is a crucial aspect of patient care. Previous studies, with the exception of one. indicate that oncologists often fail to detect general distress and do not identify those patients with significant psychological disorder. As approximately 25-30% of patients expe...

Task force #3--getting results: who, where, and how? 33rd Bethesda Conference.

the North Karelia Hypertension Program, 1972–1977. Med Care 1986;24:767–80. 60. Littenberg B, Garber AM, Sox HC, Jr. Screening for hypertension. Ann Intern Med 1990;112:192–202. 61. Edelson JT, Weinstein MC, Tosteson AN, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407– 13. 62. Laaser U, Wenzel H. A...